Tectonic Therapeutics TECX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $236.89M-22.8% | $253.8M+79.0% | $269.51M+68.8% | $287.97M+55.1% | $306.83M+1,487% | ||
| $239.89M-22.5% | $257.36M+75.2% | $273.24M+68.0% | $290.85M+55.2% | $309.64M+237% | ||
| $1.02M-47.0% | $1.19M— | $1.41M— | $1.68M— | $1.92M— | ||
| $246.58M-21.7% | $261.04M+70.7% | $277M+64.2% | $295.31M+52.3% | $314.83M+241% | ||
| $2.55M-59.2% | $1.09M+12.0% | $1.49M-43.6% | $2.8M-31.4% | $6.25M+2,474% | ||
| $265K-44.2% | $344K— | $413K— | $451K— | $475K— | ||
| $12.96M-4.1% | $9.67M-16.7% | $9.37M-45.9% | $11.36M-56.3% | $13.51M+285% | ||
| $16.16M+17.2% | $9.71M-20.0% | $9.47M-48.4% | $11.55M-58.1% | $13.79M+293% | ||
| $2K-100.0% | $2K0.0% | $150M0.0% | $150M0.0% | $150M+3,749,900% | ||
| -$247.98M-50.8% | -$222.74M-49.9% | -$203.51M-49.4% | -$184.48M-55.7% | -$164.49M+66.0% | ||
| $230.42M-23.5% | $251.33M+78.5% | $267.53M+77.9% | $283.77M+70.6% | $301.04M+402% | ||
| $246.58M-21.7% | $261.04M+70.7% | $277M+64.2% | $295.31M+52.3% | $314.83M+241% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Tectonic Therapeutics's total assets?
- Tectonic Therapeutics (TECX) holds $246.6M in total assets, down 21.7% year over year.
- How much debt does Tectonic Therapeutics have?
- Tectonic Therapeutics carries $4.9M in total debt against $230.4M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Tectonic Therapeutics have?
- Tectonic Therapeutics holds $236.9M in cash and equivalents.
- Can Tectonic Therapeutics cover its short-term obligations?
- Its current ratio is 18.51 — current assets exceed current liabilities.
- Where does Tectonic Therapeutics's balance sheet data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.